menu
    • menu

    Company profile for Edgewise Therapeutics

    NEW Drugs in Dev.: 4
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Edgewise Therapeutics is a new company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise builds on our extensive experience in ...
    Edgewise Therapeutics is a new company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise builds on our extensive experience in drug development and skeletal muscle research. We have built a custom discovery workshop for the discovery and optimization of novel therapeutics for a broad set of indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Edgewise TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3415 Colorado Ave Boulder, CO 80303
    Telephone
    Telephone
    303.735.8373
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://edgewisetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/edgewisetx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Edgewise Therapeutics To Present At J.P. Morgan Healthcare Conf
    Edgewise Therapeutics To Present At J.P. Morgan Healthcare Conf

    06 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-on-january-13-2026-302653408.html

    PR NEWSWIRE
    06 Jan 2026
    Share Share
    Edgewise Reports Inducement Grants as permitted by Nasdaq Rules
    Edgewise Reports Inducement Grants as permitted by Nasdaq Rules

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302651849.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    Edgewise Therapeutics Completes EDG-7500 Phase 2 Trial
    Edgewise Therapeutics Completes EDG-7500 Phase 2 Trial

    24 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-announces-completion-of-the-edg-7500-cirrus-hcm-phase-2-parts-b-and-c-and-favorable-interim-safety-results-from-the-ongoing-part-d-study-in-hypertrophic-cardiomyopathy-302649113.html

    PR NEWSWIRE
    24 Dec 2025
    Share Share
    Edgewise Therapeutics Reports Nasdaq Inducement Grants
    Edgewise Therapeutics Reports Nasdaq Inducement Grants

    02 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302629652.html

    PR NEWSWIRE
    02 Dec 2025
    Share Share
    Edgewise Therapeutics Appoints Christopher Martin To Board
    Edgewise Therapeutics Appoints Christopher Martin To Board

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-appoints-commercial-biotech-executive-christopher-martin-to-its-board-of-directors-302620999.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Edgewise Names R. Michael Nofi CFO as Carruthers Retires
    Edgewise Names R. Michael Nofi CFO as Carruthers Retires

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/edgewise-therapeutics-announces-appointment-of-michael-nofi-as-chief-financial-officer-and-the-retirement-of-current-cfo-r-michael-carruthers-302609547.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search